Best Free Stock Screeners in 2026: The Value Investor's Guide
Finding undervalued stocks shouldn't cost you money. That's the irony of most βpremiumβ stock screeners β they charge you $50+/month for data that's largely available for free.
We spent weeks testing every major free stock screener to answer one question: which ones actually help value investors find bargain stocks?
Here's what we found.
Why Value Investors Need a Stock Screener
Benjamin Graham screened stocks by hand. He'd flip through Moody's manuals, calculate price-to-earnings ratios with a pencil, and build spreadsheets on paper. It worked β but it took weeks to analyze a handful of companies.
Today, a good stock screener does Graham's work in seconds. You plug in your criteria β low P/E, high dividend yield, strong balance sheet β and get a filtered list of candidates worth researching further.
But not all screeners are built for value investing. Many focus on day trading signals, technical indicators, or momentum plays. Value investors need fundamental data: earnings, book value, debt ratios, cash flow, and dividend history.
That's what we tested for.
How We Evaluated Each Screener
We judged each screener on five criteria that matter most to value investors:
- Fundamental filters β Can you screen for P/E, P/B, dividend yield, debt-to-equity, free cash flow, and Graham Number?
- Data quality β Is the financial data accurate, current, and comprehensive?
- Ease of use β Can a beginner set up a value screen in under 5 minutes?
- Free tier limitations β What's actually free vs. locked behind a paywall?
- Export & save β Can you save screens and export results?
We also used our own intrinsic value calculator to cross-check valuations from each screener.
Quick Comparison Table
| # | Screener | Best For | Value Filters | Ease of Use | Free Tier | Rating |
|---|---|---|---|---|---|---|
| 1 | Finviz | Overall best free screener | β β β β β | β β β β β | Excellent | 9.2/10 |
| 2 | TradingView | Global markets + charting | β β β β β | β β β β β | Very Good | 8.8/10 |
| 3 | Zacks | Earnings-focused screening | β β β β β | β β β ββ | Very Good | 8.5/10 |
| 4 | Yahoo Finance | Beginners | β β β ββ | β β β β β | Excellent | 8.2/10 |
| 5 | Stock Rover | Deep fundamental research | β β β β β | β β β ββ | Limited | 8.0/10 |
| 6 | Simply Wall St | Visual analysis | β β β β β | β β β β β | Limited | 7.8/10 |
| 7 | MarketBeat | Dividend screening | β β β ββ | β β β β β | Good | 7.5/10 |
| 8 | Wisesheets | Spreadsheet power users | β β β β β | β β βββ | Limited | 7.3/10 |
#1. Finviz β Best Overall Free Stock Screener (9.2/10)
Finviz (Financial Visualizations) has been the gold standard for free stock screening since its launch in 2007. For value investors, it's hard to beat.
Finviz offers over 70 screening filters organized into three tabs: Descriptive, Fundamental, and Technical. The fundamental tab alone covers everything a Graham-style investor needs:
- P/E ratio (forward and trailing)
- P/B ratio and price-to-free-cash-flow
- Dividend yield with payout ratio
- Debt-to-equity ratio
- Return on equity and return on assets
- EPS growth (past 5 years and next 5 years)
- Current ratio for balance sheet strength
The free heat maps are also incredibly useful β you can instantly see which sectors and industries are overvalued or undervalued relative to the market.
Pros: Most comprehensive free fundamental filters, beautiful heat maps, fast interface, no account required.
Cons: Free tier uses 20-minute delayed data, no portfolio tracking, limited charting vs. TradingView.
Pricing: Free (delayed data) | Finviz Elite: $39.50/month (real-time data, backtesting).
Best for: Intermediate to advanced value investors who want maximum filtering power without paying a dime.
Pro tip: Set up a Graham-style screen with P/E under 15, P/B under 1.5, current ratio over 2, and positive EPS growth. You'll get a solid starting list for further research with our intrinsic value calculator.
#2. TradingView β Best for Global Markets + Charting (8.8/10)
TradingView is primarily known as a charting platform, but its stock screener is legitimately excellent β and covers global markets that most free screeners ignore.
TradingView's screener covers stocks across 100+ exchanges worldwide. If you're looking for undervalued companies in emerging markets or international dividend payers, this is your tool. The screener includes P/E, P/B, dividend yield, debt-to-equity, current ratio, revenue growth, and ROE β plus the ability to jump seamlessly from results to interactive charts.
Pros: 100+ global exchanges, best-in-class charting, modern interface, strong community, excellent mobile app.
Cons: Free tier limits to 1 screener layout, some data locked behind paywall, community can be distracting.
Pricing: Free (basic) | Essential: $14.95/mo | Plus: $29.95/mo | Premium: $59.95/mo.
Best for: Value investors who want world-class charting or screen international markets.
#3. Zacks Investment Research β Best for Earnings-Focused Screening (8.5/10)
Zacks has been a staple of investment research since 1978. Their proprietary Zacks Rank system rates stocks 1-5 based on earnings estimate revisions β adding an important dimension beyond βis this stock cheap?β to βare analysts raising or lowering estimates?β
The screener includes Zacks Rank, P/E (trailing and forward), PEG ratio, extensive EPS data across quarters and years, dividend yield, and debt-to-equity.
Pros: Unique Zacks Rank, deepest earnings data of any free screener, hundreds of criteria, custom value ranges.
Cons: Dated interface, best features need Zacks Premium ($249/year), aggressive upsells.
Best for: Value investors who prioritize earnings analysis. Pairs perfectly with Benjamin Graham's approach.
#4. Yahoo Finance β Best for Beginners (8.2/10)
Yahoo Finance may not be the most powerful screener, but it's the most accessible. Dead simple β pick filters from dropdowns, adjust ranges with sliders, get results instantly. No learning curve, no account required.
Available filters include P/E, forward P/E, price-to-book, dividend yield, market cap, 52-week change, and revenue/earnings growth. Every result links to comprehensive stock pages with financials, analyst estimates, and SEC filings β all free.
Pros: Most beginner-friendly, no account needed, excellent stock detail pages, available everywhere.
Cons: Fewer filters than Finviz, no intrinsic value calculations, ad-heavy, limited exports.
Best for: Brand-new investors. Start here, then graduate to Finviz. Check our P/E ratio guide if you need a refresher.
#5. Stock Rover β Best for Deep Fundamental Research (8.0/10)
Stock Rover is built specifically for fundamental analysis with 10 years of financial data, side-by-side comparison tools, pre-built Graham-inspired screens, and detailed scoring on valuation, growth, and financial health.
Pros: Deepest fundamental data available, pre-built value screens, excellent comparison tools, 10 years of history.
Cons: Free tier very limited (18 criteria), requires account, learning curve.
Pricing: Free (18 criteria) | Essentials: $7.99/mo | Premium: $17.99/mo | Premium Plus: $27.99/mo.
Best for: Serious buy-and-hold investors. Pairs with our balance sheet guide.
#6. Simply Wall St β Best for Visual Analysis (7.8/10)
Simply Wall St uses infographics instead of spreadsheets. Its βSnowflakeβ analysis breaks stocks into five dimensions: Value, Future, Past, Health, and Dividend. Includes visual DCF-based intrinsic value estimates, portfolio analysis, and dividend safety scores.
Pros: Most visually appealing, makes complex data accessible, built-in intrinsic value calculations.
Cons: Free tier limited to 5 analyses/month, can oversimplify, premium is $120/year.
Best for: Visual learners. Compare its estimates with our free intrinsic value calculator.
#7. MarketBeat β Best for Dividend Screening (7.5/10)
MarketBeat excels at dividend data β yield, growth rates (1/3/5-year), payout ratio, ex-dividend dates, analyst consensus, and earnings surprise history. Essential for income-focused value investors.
Pros: Best dividend-specific data, clean interface, real-time analyst changes, earnings tracking.
Cons: Fewer fundamental filters, aggressive upsells, All Access costs $449.88/year.
Best for: Dividend-focused investors. See our best dividend stocks for 2026 and dividend investing guide.
#8. Wisesheets β Best for Spreadsheet Power Users (7.3/10)
Wisesheets is a Google Sheets / Excel add-on that pulls live financial data into your spreadsheets. Build custom Graham Number calculators, custom screening formulas, backtest strategies, and create DCF models with live data feeds.
Pros: Ultimate flexibility, familiar environment, any screening criteria, historical data.
Cons: Requires spreadsheet proficiency, 50 free calls/month, not a traditional screener.
Best for: Advanced investors who live in spreadsheets and build their own DCF models.
Our Recommendation: How to Use Multiple Screeners Together
Here's our recommended workflow for value investors:
- Cast a wide net with Finviz β P/E under 15, P/B under 1.5, dividend yield over 2%, current ratio over 1.5. You'll get 20-50 candidates.
- Check earnings quality with Zacks β Eliminate stocks with Zacks Rank 4 or 5 (sell/strong sell).
- Visualize with Simply Wall St β Use the snowflake to spot red flags.
- Calculate intrinsic value β Use our free calculator to find stocks trading 25%+ below fair value β your margin of safety.
- Deep dive with Stock Rover β Compare your final 5-10 candidates side by side.
The Bottom Line
Finviz is the best free stock screener for value investors in 2026. It offers the most comprehensive fundamental filters, a clean interface, and doesn't lock essential features behind a paywall. Every value investor should have it bookmarked.
But no single screener does everything. The smartest approach is combining 2-3 free screeners with our intrinsic value calculator to build a complete value investing research workflow β all without spending a dime.
The tools are free. The knowledge is free. The only thing standing between you and finding undervalued stocks is the time to learn how to use them.
Start screening. Start investing. Start building wealth.
Frequently Asked Questions
What is a stock screener?
A stock screener is a tool that filters stocks based on criteria you set β like P/E ratio, dividend yield, market cap, or earnings growth. It helps you narrow down thousands of stocks to a manageable list of candidates worth researching.
Is a free stock screener good enough for value investing?
Absolutely. Free screeners like Finviz and Zacks provide all the fundamental filters that value investors need. Premium features like real-time data and backtesting are nice, but they're not essential for a buy-and-hold strategy.
What filters should value investors use?
Start with these classic Benjamin Graham filters: P/E ratio under 15, price-to-book under 1.5, current ratio over 2, positive earnings growth over 5 years, and dividend yield over 2%. Read our Graham formula guide for the full methodology.
How often should I screen for stocks?
For value investors, weekly or biweekly screening is sufficient. You're looking for long-term opportunities, not day-trading signals. Market dips and earnings season are particularly good times to run screens.
Can I use a stock screener on my phone?
Yes β TradingView and Yahoo Finance both have excellent mobile apps with built-in screeners. Finviz works well in mobile browsers but doesn't have a dedicated app.
Found stocks with a screener? Calculate their true value.
Use our free intrinsic value calculator to determine if a stock is actually undervalued β no signup required.
Try the Free Calculator βGet Our Best Stock Picks β Free
Join 10,000+ value investors. Get our top undervalued stock picks, Graham-style analysis, and dividend recommendations delivered to your inbox every week.
No spam, ever. Unsubscribe anytime.
Disclaimer: This article is for educational purposes only and does not constitute financial advice. Stock screener ratings are based on our independent testing and may not reflect your specific needs. Some links in this article may be affiliate links β we may earn a commission if you sign up for a paid plan, at no extra cost to you. Always do your own research before making investment decisions. Past performance is not indicative of future results.